- Home
- AEAQ vs TKNO Comparison
AEAQ vs TKNO Comparison
Compare AEAQ & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AEAQ | TKNO |
|---|---|---|
| Founded | 2025 | 1996 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.6M | 268.1M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AEAQ | TKNO |
|---|---|---|
| Price | $10.08 | $9.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 121.4K | ★ 213.4K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $9.87 | $1.91 |
| 52 Week High | $10.10 | $9.48 |
Technical Indicators
Market Signals| Indicator | AEAQ | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 61.84 | 78.77 |
| Support Level | $9.88 | $2.71 |
| Resistance Level | $10.09 | N/A |
| Average True Range (ATR) | 0.01 | 0.51 |
| MACD | -0.00 | 0.20 |
| Stochastic Oscillator | 71.43 | 93.17 |
Price Performance
Historical ComparisonAbout AEAQ Activate Energy Acquisition Corp. Class A Ordinary Share
Activate Energy Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.